Evidence map›Paper›PMID 41786881›Full record

ArticleScientific reports2026

Multivariable AI-based analysis of immune-lifestyle patterns associated with recurrent pregnancy loss: an exploratory retrospective study.

Mohsen Dashti, Lida Aslanian-Kalkhoran, Sare Doustfateme, Afsaneh Ghasemzadeh, Maryam Daraei, Shahla Danaii, Nazila Najdi, Katayoun Berjis, Javad Ahmadian Heris, Forough Chakari-Khiavi and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mohsen DashtiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0003-4455-7858
Lida Aslanian-KalkhoranImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sare DoustfatemeDepartment of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Afsaneh GhasemzadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Maryam DaraeiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahla DanaiiGynecology Department, Eastern Azerbaijan ACECR ART center, Eastern Azerbaijan branch of ACECR, Tabriz, Iran.
Nazila NajdiDepartment of Obstetrics and Gynecology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Katayoun BerjisMirza Koochak Khan Infertility Center, Tehran University of Medical Sciences, Tehran, Iran.
Javad Ahmadian HerisDepartment of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0002-6210-330X
Forough Chakari-KhiaviImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shima KarimiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahrzad RahimifarSanofi Medical Department, Tehran, Iran.
Sara DavoodiInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sina BaharaghdamImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Pegah KeramatiSamar Centre of Infertility and Recurrent Miscarriages, Shiraz, Iran.
Jaleh ZolghadriSamar Centre of Infertility and Recurrent Miscarriages, Shiraz, Iran.
Arvin AmiriFertility Technologies, Melbourne, Australia.
Mehdi YousefiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. yousefime@tbzmed.ac.ir.ORCID http://orcid.org/0000-0003-0099-6728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Approximately 1-5% of pregnant women experience recurrent pregnancy loss (RPL). Early detection and evaluation of high-risk variables allow for the initiation of recommended treatments while also reducing the likelihood of RPL in these couples. Objective The goal of this study was to build a deep learning model to identify an immune-lifestyle pattern in RPL patients based on clinical and laboratory findings. Methods We retrospectively collected the data from 16,818 RPL patients and 19,979 healthy women from across five clinics throughout Iran from December 2014 to April 2024. Fundamental population size and laboratory symptoms were gathered from the all-available data of participants. Data preprocessing involved cleaning and partitioning the data into training and validation groups. We used 22 characteristics to identify patterns via a deep learning model (TabNet). The model performance was evaluated using a confusion matrix, precision-recall curve, calibration plot, and Receiver Operating Characteristics (ROC) curve. Results The model showed robust and practical performance in identifying an immunological pattern based on the selected variables. The model yielded an AUC of 0.985, an accuracy of 0.946, a precision of 0.936, a specificity of 0.921, and a sensitivity of 0.968. Over-fitting was mitigated via repeated 5-fold cross validation (CV); no feature leakage detected. Conclusion Patterns linking immune and lifestyle factors to pregnancy loss were identified with high reliability using a deep learning approach. These findings may support a deeper understanding of the biological mechanisms underlying RPL and help guide the development of targeted treatment strategies.

Indexed as

Abortion, HabitualLife StyleAdultDeep LearningFemaleHumansIranMultivariate AnalysisPregnancyRetrospective StudiesROC CurveDeep leaningRecurrent miscarriageRecurrent pregnancy lossRisk factorsTabNet

Identifiers

PMID41786881
PMCPMC12963389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.